Immune cell serum-free cryopreservation liquid and preparation method thereof

CN120982499APending Publication Date: 2025-11-21SHAOXING RES INST OF ZHEJIANG UNIV
0 Cites 0 Cited by

Patent Information

Application Number
CN202510858706.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-06-25
Publication Date
2025-11-21

AI Technical Summary

Technical Problem

传统细胞冻存液存在冻存效果不佳、天然蛋白或血清替代物成分不明确、批次间差异大的问题,且操作繁琐、耗时长,难以满足免疫细胞治疗的需求。

Method used

采用无血清冻存液,由DMSO和DPBS构成的缓冲液,加入羟乙基淀粉、肝素钠、海藻糖、谷丙二肽和牛磺酸,通过精确配比和严格控制pH值及过滤,形成稳定的冻存液,确保细胞在冻存和复苏过程中的保护效果。

Benefits of technology

显著提高了细胞的冻存后活率和功能保持能力,降低了DMSO的毒性风险,确保了冻存液的生物安全性和稳定性,适用于大规模免疫细胞保存,满足临床研究需求。

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to an immune cell serum-free cryopreservation solution and a preparation method thereof, and belongs to the technical field of cell biology and biological pharmacy. According to the cryopreservation liquid, DMSO and DPBS are mixed according to the volume ratio of 10: 90 to form a buffer solution, hydroxyethyl starch, heparin sodium, trehalose, glutamine, HEMA and taurine are added into the buffer solution, a serum-free cryopreservation formula with definite components and high stability is formed, and the preparation method comprises the five steps of accurate component weighing, buffer solution preparation, dissolution and uniform mixing, constant volume and pH adjustment and sterilization and filtration. Wherein the component concentration can be adjusted within a preset interval according to experimental requirements, the cryopreservation liquid is suitable for immune cell preservation experiments under different conditions, the cryopreservation liquid does not contain serum components, the heterologous protein pollution risk can be remarkably reduced, and the survival rate and the biological function retention rate of cryopreserved cells are increased. The cell cryopreservation device is suitable for medium and long term cryopreservation of various immune cells such as CAR-T cells and NK cells, and has good biological safety and clinical application prospects.
Need to check novelty before this filing date? Find Prior Art